TH Insider Trading

Insider Ownership Percentage: 10.47%
Insider Buying (Last 12 Months): C$91,707.20
Insider Selling (Last 12 Months): C$0.00

Theratechnologies Insider Trading History Chart

This chart shows the insider buying and selling history at Theratechnologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theratechnologies Share Price & Price History

Current Price: C$2.17
Price Change: Price Increase of +0.02 (0.93%)
As of 12/8/2023 01:00 AM ET

This chart shows the closing price history over time for TH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Theratechnologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/1/2023Dale WeilDirectorBuy36,200C$1.38C$49,956.00
10/30/2023Joseph ArenaDirectorBuy10,000C$0.93C$9,250.00
10/27/2023Dawn SvoronosDirectorBuy15,800C$1.37C$21,646.00
10/27/2023Philippe DubucSenior OfficerBuy8,000C$1.36C$10,855.20
10/21/2022Joseph ArenaDirectorBuy2,500C$2.54C$6,353.2515,000
7/21/2022Jocelyn LafondSenior OfficerSell6,200C$2.83C$17,546.0021,800
7/19/2022Jocelyn LafondSenior OfficerSell3,000C$2.75C$8,250.0028,000
5/2/2022Joseph ArenaDirectorBuy100C$2.93C$293.247,600
10/25/2021Dale WeilDirectorBuy11,470C$4.39C$50,353.3028,170
10/22/2021Joseph ArenaDirectorBuy2,500C$4.61C$11,516.347,500
7/30/2021Joseph ArenaDirectorBuy2,000C$4.46C$8,923.202,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Theratechnologies (TSE:TH)

28.60% of Theratechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Theratechnologies Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/9/2019Monarch Partners Asset Management LLC447,990$4.26M0.6%N/A0.583%Search for SEC Filing on Google Icon
5/8/2019LLBH Private Wealth Management LLC182,631$1.74M0.6%N/A0.237%Search for SEC Filing on Google Icon
4/12/2019Virtu Financial LLC10,119$96K0.0%N/A0.014%Search for SEC Filing on Google Icon
4/9/2019Mesirow Financial Investment Management Inc.34,564$0.33M1.3%N/A0.047%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Theratechnologies logo
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Read More on Theratechnologies

Today's Range

Now: C$2.17
Low: C$2.10
High: C$2.20

50 Day Range

MA: C$2.04
Low: C$1.27
High: C$2.81

52 Week Range

Now: C$2.17
Low: C$1.22
High: C$6.48


20,292 shs

Average Volume

41,028 shs

Market Capitalization

C$106.76 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Theratechnologies?

Theratechnologies' top insider investors include:
  1. Jocelyn Lafond (Senior Officer)
  2. Joseph Arena (Director)
  3. Dale Weil (Director)
  4. Dawn Svoronos (Director)
  5. Philippe Dubuc (Senior Officer)
Learn More about top insider investors at Theratechnologies.